InvestorsHub Logo
Followers 270
Posts 8026
Boards Moderated 0
Alias Born 02/14/2009

Re: kmx_swing post# 13

Friday, 02/20/2009 1:30:30 AM

Friday, February 20, 2009 1:30:30 AM

Post# of 948
LTUS News yesterday, Lotus Pharmaceuticals announced that contractually controlled Beijing Liang Fang Pharmaceutical Co., Ltd. ("Liang Fang") entered into an intellectual rights transfer contract with Beijing Yipuan Bio-Medical Technology Co., Ltd. ("Yipuan") in December 2008 to acquire the drug Yipubishan, a highly effective and stable octreotide acetate injection solution, according to a clinical research report issued by Beijing Union Medical College Hospital Center for Clinical Pharmacology, used to treat the symptoms of gastric ulcers and hemorrhages of the upper digestive tract since 2004.

the issue with lotus for me is that their huge loan in inner mongolia could default of they dont get a bank loan.. and then they lose all their investment..

good news! adam wasserman is on the job... and he's a great CFO.

even if they lose their investment, they're selling at less than book value and will grow! yay! big money!

http://www.glenbradford.com